Invivyd (IVVD) Competitors

Nuvation Bio (NYSE:NUVB) and Invivyd (NASDAQ:IVVD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation, community ranking and profitability.

Which has more risk and volatility, NUVB or IVVD?

Nuvation Bio has a beta of 1.45, suggesting that its share price is 45% more volatile than the S&P 500. Comparatively, Invivyd has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.

Which has preferable valuation and earnings, NUVB or IVVD?

Nuvation Bio has higher revenue and earnings than Invivyd. Nuvation Bio is trading at a lower price-to-earnings ratio than Invivyd, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuvation Bio	$2.16M	343.26	-$75.80M	-$2.17	-1.02
Invivyd	N/A	N/A	-$198.64M	-$1.96	-0.90

Does the MarketBeat Community believe in NUVB or IVVD?

Nuvation Bio received 29 more outperform votes than Invivyd when rated by MarketBeat users. However, 82.61% of users gave Invivyd an outperform vote while only 80.00% of users gave Nuvation Bio an outperform vote.

Company	Underperform	Outperform
Nuvation Bio	Outperform Votes 48 80.00%	Underperform Votes 12 20.00%
Invivyd	Outperform Votes 19 82.61%	Underperform Votes 4 17.39%

Does the media prefer NUVB or IVVD?

In the previous week, Invivyd had 1 more articles in the media than Nuvation Bio. MarketBeat recorded 3 mentions for Invivyd and 2 mentions for Nuvation Bio. Invivyd's average media sentiment score of 0.98 beat Nuvation Bio's score of 0.97 indicating that Invivyd is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nuvation Bio	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Invivyd	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is NUVB or IVVD more profitable?

Nuvation Bio's return on equity of -21.89% beat Invivyd's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nuvation Bio	N/A	-21.89%	-17.86%
Invivyd	N/A	-155.33%	-114.88%

Do insiders and institutionals have more ownership in NUVB or IVVD?

61.7% of Nuvation Bio shares are owned by institutional investors. Comparatively, 70.4% of Invivyd shares are owned by institutional investors. 5.1% of Nuvation Bio shares are owned by company insiders. Comparatively, 17.9% of Invivyd shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Do analysts recommend NUVB or IVVD?

Nuvation Bio presently has a consensus price target of $8.20, indicating a potential upside of 271.88%. Invivyd has a consensus price target of $7.89, indicating a potential upside of 345.62%. Given Invivyd's stronger consensus rating and higher possible upside, analysts clearly believe Invivyd is more favorable than Nuvation Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nuvation Bio	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Invivyd	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Summary

Invivyd beats Nuvation Bio on 10 of the 17 factors compared between the two stocks.